Could antibody shots free HIV-positive kids from daily meds?
NCT ID NCT06508749
First seen May 13, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study in Botswana tests whether a combination of three lab-made antibodies can safely control HIV in children who started treatment early. About 41 kids will either receive the antibodies or pause their regular HIV medication under close monitoring. The goal is to see if these antibodies can keep the virus suppressed and protect the immune system, potentially offering a break from daily pills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Botswana Harvard Health Partnership CRS (CRS #31833)
RECRUITINGGaborone, Botswana
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Francistown CRS (CRS #31891)
RECRUITINGFrancistown, Botswana
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.